Absorbed dose measurements and predictions on LDEF

The overall radiation environment of the Long Duration Exposure Facility (LDEF) was determined in part through the use of thermoluminescent detectors (TLD's) which were included in several experiments. The results given are from four experiments (A0015 Biostack, M0004 Fiber Optics Data Link, P0004 Seeds in Space, and P0006 Linear Energy Transfer Spectrum Measurement) and represent a large fraction of existing absorbed dose data. The TLD's were located on the leading and the trailing edges and the Earth end of the spacecraft under various shielding depths (0.48 to 15.4 g/sq cm). The measured absorbed doses were found to reflect both directional dependence of incident trapped protons and shielding. At the leading edge, doses ranged from 2.10 to 2.58 Gy under shielding of 2.90 to 1.37 g/sq cm Al equivalent (M0004). At the trailing edge, doses varied from 3.04 to 4.49 Gy under shielding of 11.7 to 3.85 g/sq cm (A0015), doses varied from 2.91 to 6.64 Gy under shielding of 11.1 to 0.48 g/sq cm (P0004), and a dose range of 2.66 to 6.48 Gy was measured under shielding of 15.4 to 0.48 g/sq cm (P0006). At the Earth end of the spacecraft, doses from 2.41 to 3.93 Gy were found under shielding of 10.0 to 1.66 g/sq cm (A0015). The effect of the trapped proton anisotropy was such that the western side of LDEF received more than 2 times the dose of the eastern side at shielding depths of approximately 1 g/sq cm. Calculations utilizing a directional model of trapped proton spectra predict smaller doses than those measured, being about 50 percent of measured values at the trailing edge and Earth end, and about 80 percent near the leading edge

Three-dimensional shielding effects on charged particle fluences measured in the P0006 experiment of LDEF

Three-dimensional shielding effects on cosmic ray charged particle fluences were measured with plastic nuclear track detectors in the P0006 experiment on Long Duration Exposure Facility (LDEF). The azimuthal and polar angle distributions of the galactic cosmic ray particles (mostly relativistic iron) were measured in the main stack and in four side stacks of the P0006 experiment, located on the west end of the LDEF satellite. A shadowing effect of the shielding of the LDEF satellite is found. Total fluence of stopping protons was measured as a function of the position in the main and side stacks of the P0006 experiment. Location dependence of total track density is explained by the three-dimensional shielding model of the P0006 stack. These results can be used to validate 3D mass model and transport code calculations and also for predictions of the outer radiation environment for the Space Station Freedom

Predictions of LET spectra measured on LDEF

The linear energy transfer (LET) spectra measured by plastic (CR-39) detectors in Exp. P0006 on LDEF are much higher at high LET than expected from methods commonly used to predict LET spectra produced by the space ionizing radiation environment. This discrepancy is being investigated by examining modeling approximations used in the predictions, and some interim results are presented

Predictions of LDEF radioactivity and comparison with measurements

As part of the program to utilize LDEF data for evaluation and improvement of current ionizing radiation environmental models and related predictive methods for future LEO missions, calculations have been carried out to compare with the induced radioactivity measured in metal samples placed on LDEF. The predicted activation is about a factor of two lower than observed, which is attributed to deficiencies in the AP8 trapped proton model. It is shown that this finding based on activation sample data is consistent with comparisons made with other LDEF activation and dose data. Plans for confirming these results utilizing additional LDEF data sets, and plans for model modifications to improve the agreement with LDEF data, are discussed

Fission foil measurements of neutron and proton fluences in the A0015 experiment

Results are given from sets of fission foil detectors (FFD's) (Ta-181, Bi-209, Th-232, U-238) which were included in the A0015 experiment to measure combined proton/neutron fluences. Use has been made of recent FFD high energy proton calibrations for improved accuracy of response. Comparisons of track density measurements have been made with the predictions of environmental modeling based on simple 1-D (slab) geometry. At 1 g/cm(exp 2) (trailing edge) the calculations were approximately 25 percent lower than measurements; at 13 g/cm(exp 2) (Earthside) calculations were more than a factor of 2 lower. A future 3-D modeling of the experiment is needed for a more meaningful comparison. Approximate mission proton doses and neutron dose equivalents were found. At Earthside (13 g/cm(exp 2) the dose was 171 rad and dose equivalent was 82 rem. At the trailing edge (1 g/cm(exp 2) dose was 315 rad and dose equivalent was 33 rem. The proton doses are less than expected from TLD doses by 16 percent and 37 percent, respectively. These differences can be explained by uncertainties in the proton and neutron spectra and in the method used to separate proton and neutron contributions to the measurements

Produtos químicos como desreguladores endócrinos: substâncias danosas e como devem ser testadas

This paper presents an analysis of the opinions of different groups from: scientists, international regulatory bodies, non-governmental organizations and industry; with an interest in the problem of identifying chemical substances with endocrine disrupting activity. There is also discussion of the consequences that exposure to endocrine disruptors may have for human health, considering concrete issues related to: the estimation of risk; the tests that must be used to detect endocrine disruption; the difficulties to establish an association between dose, time of exposure, individual susceptibility, and effect; and the attempts to create a census of endocrine disruptors. Finally, it is proposed that not all hormonal mimics should be included under the single generic denomination of endocrine disruptors.This work was supported by a 96/99 Research Project from the Health Department of the Andalusian Regional Government

Toward the effective surveillance of hypospadias.

Concern about apparent increases in the prevalence of hypospadias--a congenital male reproductive-tract abnormality--in the 1960s to 1980s and the possible connection to increasing exposures to endocrine-disrupting chemicals have underlined the importance of effective surveillance of hypospadias prevalence in the population. We report here the prevalence of hypospadias from 1980 to 1999 in 20 regions of Europe with EUROCAT (European Surveillance of Congenital Anomalies) population-based congenital anomaly registers, 14 of which implemented a guideline to exclude glanular hypospadias. We also report data from the England and Wales National Congenital Anomaly System (NCAS). Our results do not suggest a continuation of rising trends of hypospadias prevalence in Europe. However, a survey of the registers and a special validation study conducted for the years 1994-1996 in nine EUROCAT registers as well as NCAS identified a clear need for a change in the guidelines for registration of hypospadias. We recommend that all hypospadias be included in surveillance, but that information from surgeons be obtained to verify location of the meatus, and whether surgery was performed, in order to interpret trends. Investing resources in repeated special surveys may be more cost-effective than continuous population surveillance. We conclude that it is doubtful whether we have had the systems in place worldwide for the effective surveillance of hypospadias in relation to exposure to potential endocrine-disrupting chemicals

Testosterone metabolism in Neomysis integer following exposure to benzo(a)pyrene

Author Posting. © Elsevier B.V., 2006. This is the author's version of the work. It is posted here by permission of Elsevier B.V. for personal use, not for redistribution. The definitive version was published in Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology 144 (2006): 405-412, doi:10.1016/j.cbpb.2006.04.001.Cytochromes P450 (CYPs) are important enzymes involved in the regulation of hormone synthesis and in the detoxification and/or activation of xenobiotics. CYPs are found in virtually all organisms, from archae, and eubacteria to eukaryota. A number of endocrine disruptors are suspected of exerting their effects through disruption of normal CYP function. Consequently, alterations in steroid hormone metabolism through changes in CYP could provide an important tool to evaluate potential effects of endocrine disruptors. The aim of this study was to investigate the potential effects of the known CYP modulator, benzo(a)pyrene (B(a)P), on the testosterone metabolism in the invertebrate Neomysis integer (Crustacea; Mysidacea). N. integer were exposed for 96h to 0.43, 2.39, 28.83, 339.00 and 1682.86μg B(a)P L-1 and a solventcontrol, and subsequently their ability to metabolize testosterone was assessed. Identification and quantification of the produced phase I and phase II testosterone metabolites was performed using liquid chromatography coupled with multiple mass spectrometry (LC-MS2). Significant changes were observed in the overall ability of N. integer to metabolize testosterone when exposed to 2.39, 28.83, 339.00 and 1682.86μg B(a)P L-1 as compared to the control animals.This research was supported by a research grant of the Ghent University Research Fund (BOF, 011.072.02). Dr. Tim Verslycke was supported by a Postdoctoral Fellowship of the Belgian American Educational Foundation

Human cerebral malaria and Plasmodium falciparum genotypes in Malawi

<p>Abstract</p> <p>Background</p> <p>Cerebral malaria, a severe form of <it>Plasmodium falciparum </it>infection, is an important cause of mortality in sub-Saharan African children. A Taqman 24 Single Nucleotide Polymorphisms (SNP) molecular barcode assay was developed for use in laboratory parasites which estimates genotype number and identifies the predominant genotype.</p> <p>Methods</p> <p>The 24 SNP assay was used to determine predominant genotypes in blood and tissues from autopsy and clinical patients with cerebral malaria.</p> <p>Results</p> <p>Single genotypes were shared between the peripheral blood, the brain, and other tissues of cerebral malaria patients, while malaria-infected patients who died of non-malarial causes had mixed genetic signatures in tissues examined. Children with retinopathy-positive cerebral malaria had significantly less complex infections than those without retinopathy (OR = 3.7, 95% CI [1.51-9.10]).The complexity of infections significantly decreased over the malaria season in retinopathy-positive patients compared to retinopathy-negative patients.</p> <p>Conclusions</p> <p>Cerebral malaria patients harbour a single or small set of predominant parasites; patients with incidental parasitaemia sustain infections involving diverse genotypes. Limited diversity in the peripheral blood of cerebral malaria patients and correlation with tissues supports peripheral blood samples as appropriate for genome-wide association studies of parasite determinants of pathogenicity.</p